Ross Owen A, Gosal David, Stone Jeremy T, Lincoln Sarah J, Heckman Michael G, Irvine G Brent, Johnston Janet A, Gibson J Mark, Farrer Matthew J, Lynch Timothy
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
Mech Ageing Dev. 2007 May-Jun;128(5-6):378-82. doi: 10.1016/j.mad.2007.04.002. Epub 2007 Apr 24.
Genetic variation of the alpha-synuclein gene (SNCA) is known to cause familial parkinsonism, however the role of SNCA variants in sporadic Parkinson's disease (PD) remains elusive. The present study identifies an association of common SNCA polymorphisms with disease susceptibility in a series of Irish PD patients. There is evidence for association with alternate regions, of protection and risk which may act independently/synergistically, within the promoter region (Rep1; OR: 0.59, 95% CI: 0.37-0.84) and the 3'UTR of the gene (rs356165; OR: 1.67, 95% CI: 1.08-2.58). Given previous reports of association a collaborative effort is required which may exploit global linkage disequilibrium patterns for SNCA and standardise polymorphic markers used in each population. It is now crucial to identify the susceptibility allele and elucidate its functionality which may generate a therapeutic target for PD.
已知α-突触核蛋白基因(SNCA)的遗传变异会导致家族性帕金森病,然而,SNCA变异在散发性帕金森病(PD)中的作用仍不明确。本研究在一系列爱尔兰PD患者中确定了常见SNCA多态性与疾病易感性之间的关联。有证据表明,在启动子区域(Rep1;比值比:0.59,95%可信区间:0.37 - 0.84)和该基因的3'非翻译区(rs356165;比值比:1.67,95%可信区间:1.08 - 2.58)中,与具有保护作用和风险的不同区域存在关联,这些区域可能独立/协同发挥作用。鉴于先前的关联报道,需要开展合作研究,利用SNCA的全球连锁不平衡模式,并标准化每个群体中使用的多态性标记。现在确定易感等位基因并阐明其功能至关重要,这可能为PD产生一个治疗靶点。